Europlasma is an Austrian company founded in 1986. Europlasma operates 7 plasma donation centres on the highest quality level in Austria and 2 in the Czech Republic, where voluntary donors can donate blood plasma. Europlasma's mission is to save lives and to make the plasma obtained available to the pharmaceutical industry as raw material for high-quality biological drugs.
The volume of plasma collected by Europlasma corresponds to the amount of plasma needed to produce pharmaceuticals for the treatment of a population the size of Austria. In addition, thrombocyte concentrates are also produced at the Donation Centre Vienna 9. Europlasma supplies these blood components to large hospitals in Vienna, Lower Austria, Burgenland as well as the LKH Graz.
Since 2010 Europlasma has been part of the LFB Group, a French company that produces life-saving drugs from plasma. LFB is a biopharmaceutical group that develops, manufactures and markets products from plasma and recombinant proteins for the treatment of patients with serious and often rare diseases. Founded in France in 1994, LFB is one of Europe's leading biopharmaceutical companies supplying mainly hospital-based healthcare professionals with therapeutics derived from blood, with the vision of offering patients treatment options in three main areas: immunology, hemostasis and intensive care. LFB currently markets 15 products in more than 30 countries. The LFB Group employs almost 2,000 people in Europe and is an important player among plasma fractionators.